SFx Asset Management: Routine Execution Status

Maximise efficiency of PC-DMIS measurement routines with HxGN SFx | Asset Management

PC-DMIS users with our support and maintenance agreement (SMA) can browse and monitor the routine execution status for all the machines in their business at the same time, on a single display, in the ‘Routine Dashboard’ of HxGN SFx | Asset Management. The view gives a visual summary of relevant statistics about measurement routines, such as Run History, Execution Time and Dimension Summary. 

SFx Asset Management is a cloud-based subscription service, delivered through an online dashboard, which provides routine-specific and dimension-specific data for PC-DMIS users to browse and monitor the Routine status and execution conditions run on all CMMs.

The Routine Detail View enables users to drill down into a detailed view of a specific routine, including Process Information (Started / Completed / Paused / Cancelled / Error / Dimension Failed), Routine measurement results (Pass / Fail, Deviation and Out Of Tolerance) and Routine History (Run Date, Asset and Execution Time).

PC-DMIS users with an SMA also receive instant event notifications about specific Routines (for Started / Completed / Paused / Cancelled / Error / Dimension Failed) on all assets. Events are logged for later analysis.

Do you have an SMA licence of PC-DMIS? Try the SFx Asset Management Routine Dashboard now!

Learn more: HxGN SFx | Asset Management - How To Connect

問い合わせ先

Hexagon Manufacturing Intelligence
ヘキサゴン・メトロジー株式会社(本社)
〒252-0132 神奈川県相模原市緑区橋本台 
1-15-8
Sagamihara-shi (Kanagawa-Ken)
Japan

T: +81 42 700 3500
F: +81 42 700 3511

販売・営業部門 カスタマーサービス部門

Get Started!

Create an account or login to access key machine performance data

Sign Up Log in

What’s new in HxGN SFx | Asset Management?

See what’s new in the latest release of HxGN SFx | Asset Management

Case Study: Paragon Medical

Hear from Paragon Medical, an early adopter of HxGN SFx | Asset Management, about the benefits of using facotry asset management in the heavily regulated medical technology...